Global capabilities
Delivering value beyond the test result
At Mayo Clinic Laboratories, laboratory medicine is about more than a test result — it’s about everything that contributes to providing answers for your patients. We develop individualized support solutions for each client that extend through all aspects of the relationship to ensure the delivery of answers, not just results.
Specialized testing areas include:
Global logistics and shipping
We develop unique relationships with each client to individualize logistics support, which is coordinated by a local team who ensures a seamless process before the first patient specimen is sent. Our specialists collaborate with packaging suppliers to create unique solutions that extend the stability of specimens traveling around the world.
These experts ensure specimens are handled carefully and efficiently through close connections to shipping carriers. The air carriers we work with are experienced with processing clinical specimens.
Optimized, expeditious processing
We recognize many medical conditions have a window of opportunity for the best possible outcomes. Our tests and processes are optimized to better serve patients and deliver results with outcomes in mind. We do not triage specimens across a network of labs or use a batch-testing business model. Result turnaround times are expedited by:
- Running tests continuously – your samples are processed alongside those from Mayo Clinic.
- A testing approach that incorporates comprehensive panels and algorithms when appropriate.
- Utilization of Lean and Six Sigma processes.
Reliable connectivity
We offer technology solutions to help our clients connect to us, including a secure online portal with interfacing capabilities that allows you to easily order tests and receive results. Our solutions include:
- Client-friendly test ordering through MayoLINK, which is available in eight languages.
- Expansive website with links to our open- access test catalog, which is updated daily and features comprehensive clinical information, including specimen requirements; clinical and interpretative information; performance; sample test reports; setup files; and pricing.
- 30 country-specific toll-free numbers.
News and updates
The latest
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, welcomes William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories. Together, they discuss recent news about virus activity and explore the value of collaboration in shaping innovative diagnostic strategies.
As a hospital account executive for Mayo Clinic Laboratories, Vanessa Gonzalez Casar supports and partners with local hospitals to ensure their patients receive the right test at the right time.
Due to logistic challenges, we are experiencing shipment delays which may result in testing delays or cancelations.
The MayoComplete Liquid Biopsy Panel offers a noninvasive alternative to traditional cell-based biopsies. This allow for faster turnaround time and the ability to perform molecular DNA testing in cancer patients where tumor tissue isn’t available.
This page includes updates posted to the site during the month of December.
As part of Mayo Clinic’s Neuro-Oncology practice, the Division of Laboratory Genetics and Genomics tests about 50 brain tumors a week, and upwards of 1,500 brain tumors a year from all over the world.
Topic highlights include: Biden administration releases doses of flu medicine from national stockpile and pediatric medicine makers say they are running 24/7 to meet increased demand
Matthew Binnicker, Ph.D., director of the Clinical Virology Laboratory at Mayo Clinic, joins host Bobbi Pritt, M.D., on this week’s episode of the "Answers From the Lab" podcast. In this episode, they discuss the ongoing respiratory virus season, a new test for measles available at Mayo Clinic Laboratories, and some tips to stay healthy.
This week's research roundup features: Neuropathological findings in COVID-19: an autopsy cohort
As a result of winter weather across the U.S. and the upcoming holiday this weekend, we are experiencing logistical challenges, which may result in testing delays or cancelations.
Topic highlights include: New members-only health clinic to start seeing Rochester patients in January, A staffing expert shows how telehealth is stepping in to fill the staffing shortage, Congress reaches major health policy deal on Medicare, Medicaid, and pandemic preparedness
Blood diversion as a mechanism to lower blood culture contamination rates.
William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, joins “Answers From the Lab” for his weekly leadership update with host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic. In this episode, Drs. Pritt and Morice share their predictions for the new year and discuss why they believe 2023 will be a pivotal year for health care.